Seer
Latest round
- Series D
Last raised
- May 2020
Total raised
- $164M
Investors
- 9
About Seer
, formerly known as Seer Biosciences, Inc. operates as a biotechnology company that develops innovative solutions that act as a gateway to the proteome.D. The company's product, Proteograph™, includes optimized reagents and consumables, automation, and software. The product suite enables medical research to conduct unbiased proteomics analysis. The company generates revenue by selling its Proteograph Product Suite for research. The company plans to launch its Proteograph™ suite of products in 2021.
Who invested in Seer
9 investors across 5 rounds
See all investors in Seer
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Seer
Who invested in Seer?
Seer has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seer raised?
Seer has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Seer last raise money?
Seer's most recent round on record is a Series D, in May 2020.
What does Seer do?
, formerly known as Seer Biosciences, Inc.
Where is Seer headquartered?
Seer is headquartered in Redwood City, US.
Which VCs invest in companies like Seer?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seer's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Seer? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.